Clinical Trials on Reconstructed Bladder in Ireland
Total 90 results
-
Astellas Pharma Europe Ltd.CompletedOveractive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)Ireland
-
National University of Ireland, Galway, IrelandEnterprise IrelandCompleted
-
Mr HD FloodUnknown
-
University of LimerickCompletedMultiple Sclerosis | Urinary Bladder, Overactive | Lower Urinary Tract Symptoms | Urinary Incontinence | Urinary Bladder, Neurogenic | Urinary Incontinence, Urge | Nocturia | Bladder Dysfunction | Neurogenic Bladder Dysfunction | Urinary Frequency More Than Once at NightIreland
-
Brown UniversityLifespanTerminatedBladder Cancer | Invasive Bladder CancerUnited States
-
Women and Infants Hospital of Rhode IslandUnknownUrinary Incontinence | Urge Incontinence | Overactive Bladder Syndrome | Detrusor Instability | Detrusor HyperreflexiaUnited States
-
Brown UniversityCures Within Reach; Lifespan; Legorreta Cancer Center at Brown UniversityRecruitingUrothelial Carcinoma Bladder | Androgen Receptor PositiveUnited States
-
Medical Diagnostic Laboratories, LLCUnknownBladder Cancer | Hematuria | DysuriaUnited States
-
EvergreenHealthCompletedParkinson's DiseaseUnited States
-
Gnankang Sarah NapoeRecruitingUrinary Incontinence, Urge | Overactive Bladder SyndromeUnited States
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
Spectrum Pharmaceuticals, IncAllerganTerminatedBladder CancerUnited States, Poland, Czechia, Slovakia
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUrinary Incontinence, UrgeUnited States
-
Watson PharmaceuticalsCompleted
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
University College CorkIrish Cancer Society; Cancer Research@UCCRecruitingKidney Cancer | Prostate Cancer | Penile Cancer | Survivorship | Testicular Cancer | Urothelial Tract/Bladder Cancer, NosIreland
-
PfizerCompletedOveractive BladderUnited States
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
Urovant Sciences GmbHCompletedOveractive Bladder With Urge Urinary IncontinenceUnited States
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
University of California, San FranciscoPfizerCompletedOveractive Bladder | Urge Urinary IncontinenceUnited States
-
PfizerCompletedOveractive BladderCanada, United States, Costa Rica, Hungary, Slovakia, Spain, Colombia, India, Russian Federation, Ireland, Korea, Republic of, Germany, Sweden, Poland, Bulgaria, Estonia, Brazil, Greece, Latvia, Lithuania, Malaysia, Romania, Singapore, South Africa and more
-
PfizerCompleted
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Velicept Therapeutics, Inc.Completed
-
Duramed ResearchCompletedOveractive BladderUnited States, Canada
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
SanofiCompleted
-
AllerganCompletedUrinary Incontinence | Overactive Bladder With Urinary IncontinenceUnited States, Canada
-
Targacept Inc.CompletedOveractive BladderUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
GlaxoSmithKlineCompletedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States, Canada
-
Urovant Sciences GmbHCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary Bladder, OveractiveUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Butler HospitalNational Cancer Institute (NCI)CompletedKidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver CancerUnited States
-
OnxeoCompletedOvarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Epithelial Ovarian CancerUnited States, Denmark, United Kingdom